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ABSTRACT 
 
Recent reports have indicated different effects of immunostimulatory sequences 
containing CpG-Oligodeoxynucleotides (ODN) on various immune cells. However, the 
exact role of CpG-ODN in the human gut is unclear.  
In the present study, we assessed potential effects of CpG-ODN on non lymphoid cell 
(intestinal epithelial cell line HT-29) on a dose-response and time-course basis. Intestinal 
epithelial cell line HT-29 was treated with CpG-ODN (CpG 2006) and lipopolysaccharide 
(LPS) at 5, 10, 25, 50 μg/ ml and 1, 5, 10 μg/ ml concentrations, respectively. Following 
treatments, dose- response and time-course cytotoxicity using a colorimetric method, 
Metaloproteinase-2 (MMP-2) activity (using gelatin zymography) and apoptosis (using 
annexin-v flowcytometry method) assays were performed. Chloroquine treatment was also 
used for its inhibitory effect on endosomal acidification process to verify specific CpG-ODN 
and Toll Like Receptor 9 (TLR9) interactions.  
Cytotoxicity analysis of CpG-ODN showed that CpG-ODN increased significantly the 
proliferation of CpG-ODN treated cells, as compared to untreated cells, at concentrations of 
10-25 μg/ml (p< 0.05). Overall MMP-2 activity analysis showed significant differences 
between treated and untreated cells. However, minimal changes were observed when MMP-2 
activity was assessed per cell. Moreover, CpG-ODN treated cells demonstrated an increasing 
apoptosis rate of 0.8%, 6.46% and 14.21% at concentrations of 5, 10, 25 μg/ml, respectively.  
Collectively, our data indicated that intestinal epithelial cell line HT-29 is highly 
responsive to CpG effect in vitro and exhibits modified activities. The direct CpG-ODN and 
TLR-9 interactions in HT-29 cells could provide new approaches in malignant tumor 
therapeutic strategies. 
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INTRODUCTION 
 
Recognition of cytidine phosphorothioate guanine 
oligonucleotides (CpG-ODN), which induce signaling 
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through Toll-like receptor 9 (TLR9) is an integral part 
of the innate immune system. CpG motifs which are 
common in bacteria, but not in mammalian DNA, are 
currently under investigation as adjuvants in therapy 
against infections and cancer.1,2  
CpG oligodeoxynucleotides (ODNs) are synthetic 
DNA sequences that mimic bacterial DNA and have 
potent immunostimulatory effects on dendritic cells, B 
cells and natural killer (NK) cells.3 Murine and human 
dendritic cells and B cells express high levels of TLR9 
and respond to bacterial DNA on stimulation with 
synthetic CpG-ODNs in vitro.4-6 
Potential of CpG-ODNs as therapeutic agents and 
vaccine adjuvants has been demonstrated in animal 
models of infection disease, allergy and cancer and are 
currently undergoing clinical trails in humans.7 
The vast majority of published studies on CpG-
ODNs have explored its effect on various immune cell 
populations. Some studies have focused on effects of 
CpG-ODNs on expression of cytokines in different 
cells.8 It has recently been demonstrated that the 
administration of CpG-ODN through tape-stripped skin 
induced a Th1-type immune response and suggested 
the CpG-ODN for vaccinological applications.9 
Induction of direct tumoritoxic responses by the 
cells of the innate immune system might help to induce 
antitumour reactions through different recognition and 
destructive pathways than those used by T cells. 
Macrophages, the effector cells of the innate immune 
system, can play an important role in antitumour 
immune reactions. While involved in tumour 
development and progression; macrophages can also be 
activated to destroy cancer cells via both cell contact-
dependent and -independent mechanisms. In a recent 
study to determine the effect of CpG therapy on 
macrophage activation, Buhtoiarov et al. showed that 
cytotoxic macrophage, rather than T cells or NK cells, 
can also play a role in antitumour reactions against 
weakly immunogenic tumours during immunotherapy 
with CpG-ODN.10  
However, a few investigators have reported direct 
effect of CpG-ODNs on non immune cells. Some 
studies revealed constitutive expression of mRNA for 
TLR9 in three human colonic epithelial cell lines, HT-
29, Caco2 and T84.11 Toll-like receptors (TLRs) are 
essential in the host defense against infections and sofar 
10 human TLRs (TLR1-TLR10) and one TLR-
homolog (RP105) have been characterized.12  Although 
studies in cell lines and murine colitis models strongly 
suggest that TLRs including TLR9 play a role in 
recognition and response to bacterial products in the 
gut, the experimental results are conflicting.13-15 
Anticancer agents ultimately kill cancer cells by 
inducing the apoptotic cell-suicide pathway. There is 
evidence that CpG-ODNs bear anti-proliferative 
properties. The effects appear to be mediated both by 
the down-regulation of IL-10 production and increased 
apoptosis.16,17 These findings provide a major part of 
the rationale to assess the proapototic and anti-
proliferative potentials of CpG-ODNs.  
Moreover, Matrix metalloproteinases (MMPs), a 
family of related proteinases, are responsible for 
degradation and remodeling of extracellular matrix. 
These enzymes are over expressed in many tumors and 
there is solid evidence that they play a key role in the 
malignant progression and invasiveness of many 
tumors.18 We assessed, therefore, the effects of CpG-
ODNs on MMP-2 activity. 
The aim of the present study was to investigate the 
direct effects of CpG 2006 on human colon carcinoma 
cell line HT-29 characteristic phenotypes as assessed 
by cytotoxicity, MMP-2 activity, and apoptosis.  
 
MATERIALS AND METHODS 
 
Cell Line 
The intestinal epithelial cell line HT-29 was 
purchased from National Cell Bank of Pasteur Institute 
of Iran, Tehran, Iran. 
 
CpG-ODN 2006 and 2006C 
The CpG-ODNs sequences used in this study were 
selected according to published reports1 and were 
commercially synthesized (AlphaDNA, Montreal, 
Canada). ODN 2006C was used as CpG control 
desoxyoligunucleotide.  
 
LPS 
Lipopolysaccharide was obtained from Sigma-
Aldrich (Germany).  
 
Cell Culture 
The cell line HT-29 was seeded at an initial density 
of 10,000 cells / well in 96-well tissue culture plate. 
Cells were maintained in DMEM medium 
supplemented with 10% fetal calf serum, 100 u/ml 
penicillin, 100 μg/ml streptomycin, with 5% CO2, at 
37°C and saturated humidity. 
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Dose-response and Time-course Treatments 
Triplicate, CpG-ODN 2006 preparations at 
concentrations of 5, 10, 25, 50 μg/ml were transferred 
to overnight cultured of HT-29 cells. Non-treated cells 
were used as controls. Cell were cultured for 24 hours, 
48 hours and 72 hours and then subjected to 
colorimetric cytotoxicity assay. A sample of each of the 
medium was also used for gelatinase zymography. 
We assessed effects of chloroquine (Daru pakhsh, 
Terhan, Iran) on CpG-ODN effects. Before treating the 
cells with CpG, they were treated to 10 μg /ml 
chloroquine for 30 minutes, then the cells were treated 
to various concentration of CpG-ODN (5,10,25,50 μg 
/ml ) followed by incubation for 24 hours and then 
colorimetric cytotoxicity and gelatin zymography were 
performed. The effect of LPS on HT-29 cell line was 
also evaluated at concentrations of 1, 5, 10 μg/ml. 
 
Colorimetric Cytotoxicity Assay 
This method was carried out as described 
previously.19 After each experiment, cells were washed 
three times with ice-cold phosphate buffered saline 
(PBS), pH 7.2, followed by fixation in a 5 % 
formaldehyde solution. Fixed cells were washed three 
times and stained with 1 % crystal violet. The stained 
cells were washed, lysed and solublised with 33.33 % 
acetic acid solution. The density of developed purple 
color was read at 580 nm using a conventional ELISA 
reader instrument. 
 
Gelatinase Zymography 
This technique is mainly used for the detection of 
gelatinases, MMP-2 and MMP-9. The zymography 
procedure was adopted according to our previous 
publication.20 It is extremely sensitive because levels of 
10 pg of MMP-2 can be detected. Briefly, protein-
content adjusted (normalized) aliquots of conditioned 
media, in triplicate, were subjected to sodium dodecyl 
sulfate polyacrilamide gel electrophoresis (SDS-PAGE) 
containing 2 mg/ml gelatin. Electrophoresis was 
performed for 3 hours at a constant voltage of 80 volts. 
After electrophoresis, gels were gently washed three 
times with 2.5 % Triton X-100 solution to remove 
SDS. The gel slabs were then incubated at 37ºC 
overnight in 0.1 M Tris HCL gelatinase activation 
buffer (pH 7.4) containing 10 mM CaCl2. Staining was 
performed with 0.5 % coomassie brilliant blue followed 
by intensive destaining. MMP-2 proteolysis areas 
appeared as clear bands against a blue background in 
the gels. Using a UVI pro gel documentation system 
(GDS-8000, Cambridge, UK), quantitative evaluation 
of both surface and intensity of lysing bands, on the 
basis of grey levels, were compared relative to non–
treated control wells and expressed as Relative 
Expression of gelatinolytic activity. To determine the 
CpG mode of action, a set of treatments and analyses 
were performed on cell-free media.  
 
Cell Apoptosis Assay 
The cells were treated to various concentrations of 
CpG-ODN 2006 (5,10,25,50 μg/ml) and incubated for 
24 hours and harvested cells were stained with FITC-
cojugated annexin-v (IQ Products Germany) and 
propidium iodide. The cell death was assessed by 
flowcytometry. Apoptotic and total cells were counted 
by flowcytometry instrument (Partec PAS Germany). 
The results were expressed as percentage of apoptotic 
to necrotic cells. 
 
Statistical Analysis 
The differences in cell proliferation and gelatinase 
activity were compared using Kruskal-wallis Test. P 
values <0.05 were considered significant. 
 
RESULTS 
 
Cytotoxic Analysis of CpG-ODN and LPS 
Figure 1 shows the proliferative response of 
epithelial cell line HT-29 to CpG-ODN at various 
concentrations (5, 10, 25, 50 μg/ml) and different 
times. The comparison of proliferative response 
between various concentrations showed a significant 
difference (p <0.05). 
 
 
Figure 1. Panel A: HT-29 cell line as observed in tissue 
culture plate (X40). 
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Figure 1. Panel B: Depiction of CpG cytotoxicity assay on 
HT-29 cell line. 
HT-29 cell lines were cultured (Panel A) and subjected to CpG-
ODN treatments (Panel B) at various concentrations (5-50 
μg/ml). CpG-ODN cytotoxicity was analysed at 24, 48, and 72 
hours, as indicated in Materials and Methods. 
 
Figure 2 shows inhibitory effect of chloroquine on 
CpG-ODN. There was no significant difference 
between cytotoxic effect of CpG-ODN at given 
concentrations. 
Figure 3 shows the proliferative response HT-29 
cell line to LPS at concentrations of 1, 5, 10 μg/ml 
treatments for 24 h. The comparison of proliferative 
response between various concentrations showed a 
significant difference. Moreover, the comparison of 
proliferative response to LPS and CpG-ODN treated 
groups at equal concentrations showed significant 
difference at concentrations of 5 and 10 μg/ml (p<0.05) 
(Figure 4).  
In addition, there was a significant difference on 
proliferation effects between the ordinary CpG-ODN 
2006 and CpG-ODN 2006C control (data not shown). 
 
 
Figure 2. Inhibitory effect of chloroquine on CpG-ODN. 
HT-29 cell lines were treated with 10 μg/ml chloroquine 
(30 min); then were subjected to CpG-ODN at various 
concentration (5-50 μg/ml) and cytotoxicity was analysed 
at 24 hours.  
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Figure 3. Cytotoxic effect of LPS on epithelial cell line. 
HT-29 cell lines were subjected to LPS at various 
concentrations (1-10 μg/ml) and cytotoxicity was analysed 
at 24 hours. 
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Figure 4. Comparison of cytotoxic effects of CpG-ODN 
and LPS.HT-29 cell lines were subjected to CpG-ODN 
and LPS at various concentrations (5-10 μg/ml) and 
cytotoxic effects of CpG-ODN and LPS were compared. 
 
Effect of CpG-ODN and LPS on MMP-2 Activity 
Dose response analysis of CpG-ODN on MMP-2 
activity of epithelial cell line HT-29 is presented in 
figure 5.  Overall MMP-2 activity analysis showed 
significant differences between different groups of 
treated and untreated cells (p<0.05). However, minimal 
changes were observed when MMP-2 activity was 
assessed per cell.  Assessments of cell-free media 
showed no difference in treatments versus untreated 
supernatant, indicating that CpG effects on cells are 
direct rather than on enzyme alone.    
 
Effect of CpG-ODN on Apoptosis 
As depicted in figure 6, the rates of apoptosis to 
necrosis for CpG-ODN at concentrations of 5, 10, 25 
μg/ml were 0.8 %, 6.46%, 14.21%, respectively. These 
results show that apoptosis occurred significantly 
higher in CpG-ODN treated cells, as compared to un-
treated cells (p<0.05). 
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Figure 5. Dose response and time course analysis of CpG-ODN effect on MMP-2 activity. HT-29 cell lines were incubated 
with doses of CpG-ODN (0=untreated, 5, 10, 25, 50 μg/ml) for 24, 48, 72 hours, in triplicates, as described in "Materials and 
Methods". A representative zymogram gel for each treatment set was depicted on top of the histogram. 
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Figure 6. Assessment of apoptosis by flowcytometery. The 
apoptosis assay revealed that the rate of apoptosis as 
compared to necrosis was 0.8 %, 6.46 % and 14.21 % at 
concentrations of 5,10 and 25 μg/ml, CpG-treatments, 
respectively. The number of apoptotic cells was 
demonstrated as percentage of apoptosis to necrosis in a 
given gated area. 
 
DISCUSSION 
 
Study of the antitumour properties of 
immunostimulatory CpG-ODN represent a rapidly 
expanding field of experimental and applied 
immunology.10 
This study was aimed at determining the influence 
of CpG-ODN on epithelial cell line HT-29 that 
expresses TLR9 (specific receptor for CpG-ODN). The 
CpG-ODN 2006 was selected due to its strong 
immunostimulatory activity in human mononuclear 
cells.22 Pedersen et al reported that CpG-ODN exposure 
induced no significant change in viability in colonic 
epithelial cells as judged by MTT metabolism.1 In 
contrast, cytotoxicity analysis for CpG-ODN-treated 
cells in the present study revealed that CpG-ODN (CpG 
2006) significantly increased proliferation of epithelial 
cell line HT-29 as compared to untreated cells. 
However, treatment of cells with CpG-ODN at 
concentration of 50 μg/ml showed a lower proliferative 
response than 25 μg/ml indicating that CpG-ODN 
might exhibit some cytotoxic potential at high dose 
administrations. A report on intestinal epithelial cells 
proliferation in proximal small intestinal biopsy 
specimens from children showed increased 
proliferation rates in a wide range of enteropathies for 
instance enteropathogenic E coli enteritis.23 
MMP-2 activity was also assessed in this study. 
One of the critical steps for tumor invasion and 
metastasis is the destruction of extracellular matrix, 
which is catalyzed mainly by the MMPs.24 Thus; 
inhibition of MMPs could be beneficial in preventing 
tumor metastasis. Some studies found that MMP-2 was 
overexpressed in colorectal adenocarcinomas and 
weakly expressed in non cancer mucosa.25 In another 
report Merrell et al. found that CpG oligonucleotide 
treatment decreased tissue inhibitor of metallo-
proteinase-3 expression and increased the levels of 
active MMP-13 in TLR9-expressing but not TLR9(-) 
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breast cancer cells without affecting MMP-8.26 They 
also proposed a new molecular target for cancer 
therapy, since TLR9 has not previously been associated 
with cancer invasiveness. In a recent study regarding 
the TLR9 expression and function in human prostate 
cancer (CaP) cells, Ilvesaro et al. reported that 
treatment of TLR9(+), but not TLR9(-) CaP cells with 
CpG-ODNs increased their invasion, which was 
inhibited with chloroquine. CpG-ODN treatment also 
increased MMP-13 activity and neutralizing anti-
MMP-13 antibody prevented CpG-ODN-induced 
invasion in TLR9(+) CaP cells.27 The results of these 
reports might be in accordance with our presented data. 
As depicted in figure 5, overall MMP-2 activity 
analysis in our study showed significant differences 
between different groups of treated and untreated cells. 
However, minimal changes were observed when MMP-
2 activity was assessed per cell, as elaborated in a dose 
response fashion. The CpG effect on MMP-2 activity 
indicates a very sensitive dose-dependent modulatory 
pattern, which calls for further investigations for 
verification of effective clinical applications. We 
performed paralleled paired zymography tests to 
determine whether CpG-ODN effects could also be 
detected in the absence of HT-29 cells. Interestingly, no 
direct chemical interaction was found between CpG 
and MMP-2 when HT-29 cells were depleted from the 
medium. 
A number of recent reports indicate that TLR 
expression might have the potential to induce apoptosis 
upon ligand binding. 28,29 It has also been demonstrated 
that CpG DNA inhibits spontaneous apoptosis of 
dendritic cells.30 Some investigators showed that 
stimulation with CpG-ODN resulted in a strongly 
increased sensitivity of TLR9-expression in fibroblasts 
to apoptosis induced by staurosporine and UV-
irradiation advocating that TLR9 signaling can 
sensitize fibroblasts for apoptosis.31 In contrast, rescue 
of both splenic B cells and WEHI-231 cells from 
apoptosis have been reported upon CpG treatments.32 
Our data obtained from apoptosis assay showed 
induction of cell apoptosis by CpG-ODN. Further 
comparative analysis revealed that in the background of 
decreasing necrosis rate with higher CpG 
concentrations, the apoptosis to necrosis ratio is 
increased indicating that the relative number of 
apoptotic cells are increased at higher CpG 
concentrations (Figure 6). 
In conclusion, intestinal epithelial cell line HT-29 is 
potentially highly responsive to CpG treatment in vitro 
and exhibits deviated cancer cell characteristic 
phenotypes.  
Our data support the role of CpG in HT-29 cell 
function and provide a rationale for further clinical 
development of CpG therapy in patients with malignant 
intestinal tumors. The potential pro-apoptotic capacity 
of CpG therapy on colonic cancer HT-29 cell line is 
promising in further anti-cancer cell therapies. 
Moreover, studies on the mediators that have the 
potential to orchestrate onset of the mucosal 
inflammatory responses, T cell activation, and 
regulation of apoptosis signaling processes are also 
recommended. 
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